One of the first findings implicating FHR-4 in the pathophysiology of AMD came from a GWAS that identified a correlation between the CFHR4 intron 1 variant rs6684931, systemic complement activation levels (serum C3d/C3 ratio) and increased risk for AMD41. Here, CFHR4 is linked to age-related macular degeneration.